Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ying-Shu You"'
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 3, Pp 513-520 (2024)
Abstract Background and Objective The complex risk factors of liver injury have prevented the establishment of causal relationships. This study aimed to explore the effects of antidepressant class, cumulative days of medication exposure, presence of
Externí odkaz:
https://doaj.org/article/fd64dbee8eae4bcdbec8c61f0c130b7e
Autor:
Chih-Yang Huang, Shu-Fen Chiang, Tao-Wei Ke, Tsung-Wei Chen, Ying-Shu You, William Tzu-Liang Chen, K. S. Clifford Chao
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Abstract Programmed cell death-1 (PDCD1/PD-1) and its ligand programmed cell death 1 ligand 1 (CD274/PD-L1) have been reported to suppress anti-tumor T cell-mediated immune responses. However, the clinical significance of CD274 in colorectal cancer w
Externí odkaz:
https://doaj.org/article/60b9499f2bc84bfe8d239a86ad6ce23e
Autor:
Yen-Ying Ma, Hao Lin, Jau-Sung Moh, Kuang-Den Chen, I-Wen Wang, Yu-Che Ou, Ying-Shu You, Chia-Chi Lung
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 50, Iss 2, Pp 165-171 (2011)
Objective: There is a need to develop alternative therapeutic strategies to overcome cisplatin-associated resistance in patients with ovarian cancer. Histone deacetylation (HDAC) associated with inactivation of genes has been implicated in the epigen
Externí odkaz:
https://doaj.org/article/576adc4837674648b2d7abd751a57360
Autor:
Yu Ching Lan, Chih Yang Huang, William Tzu-Liang Chen, Shu-Fen Chiang, Tao-Wei Ke, Ying-Shu You, K. S. Clifford Chao, Tsung-Wei Chen
Publikováno v:
Cancer Immunology, Immunotherapy. 68:283-296
The expression of programmed cell death 1 ligand 1 (PD-L1) and interferon-γ (IFN-γ) is of great interest for the development of chemoradiotherapy and immune checkpoint inhibitor treatments. Patients with nodal metastasis (pN+) tend to have a poor p
Autor:
Shu-Fen Chiang, Tao-Wei Ke, Chen-Yu Lin, Tsung-Wei Chen, Chih Yang Huang, William Tzu-Liang Chen, K. S. Clifford Chao, Ying-Shu You
Publikováno v:
Cell Death and Disease, Vol 9, Iss 10, Pp 1-15 (2018)
Cell Death & Disease
Cell Death & Disease
Dysfunctional mitochondria have been shown to enhance cancer cell proliferation, reduce apoptosis, and increase chemoresistance. Chemoresistance develops in nearly all patients with colorectal cancer, leading to a decrease in the therapeutic efficaci
Autor:
Ying-Shu You, Jen-Hau Chen, Hao-Jan Liang, Yen-Ching Chen, Ching-Yu Lin, Chwen-Keng Tsao, Jeng-Min Chiou, Keh-Sung Tsai, Shen-Hung Lee
Publikováno v:
Journal of Bone and Mineral Research. 29:212-222
Osteoporosis is related to the alteration of specific circulating metabolites. However, previous studies on only a few metabolites inadequately explain the pathogenesis of this complex syndrome. To date, no study has related the metabolome to bone mi
Autor:
Jau-Sung Moh, Chia-Chi Lung, Yen-Ying Ma, Ying-Shu You, I-Wen Wang, Hao Lin, Yu-Che Ou, Kuang-Den Chen
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 50, Iss 2, Pp 165-171 (2011)
Objective There is a need to develop alternative therapeutic strategies to overcome cisplatin-associated resistance in patients with ovarian cancer. Histone deacetylation (HDAC) associated with inactivation of genes has been implicated in the epigene
Autor:
T.W. Chen, Chih Yang Huang, Ying-Shu You, K.S.C. Chao, Shu-Fen Chiang, Tao-Wei Ke, Tsung-Wei Chen
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 99:S65
Autor:
Ying-Shu, You, Ching-Yu, Lin, Hao-Jan, Liang, Shen-Hung, Lee, Keh-Sung, Tsai, Jeng-Min, Chiou, Yen-Ching, Chen, Chwen-Keng, Tsao, Jen-Hau, Chen
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 29(1)
Osteoporosis is related to the alteration of specific circulating metabolites. However, previous studies on only a few metabolites inadequately explain the pathogenesis of this complex syndrome. To date, no study has related the metabolome to bone mi
Publikováno v:
Drugs - Real World Outcomes; Sep2024, Vol. 11 Issue 3, p513-520, 8p